Skip to main content
. 2022 Mar 3;12:90. doi: 10.1038/s41398-022-01804-5

Table 1.

Characteristics of patients with psychiatric disorders and severe COVID-19 receiving or not receiving FIASMA psychotropic medications at baseline (N = 545).

Exposed to any FIASMA (N = 164) Not exposed to any FIASMA (N = 381) Non-exposed matched group (N = 164) Exposed to any FIASMA vs. Not exposed Exposed to any FIASMA vs. Not exposed Exposed to any FIASMA vs. Non-exposed matched group
Crude analysis Analysis weighted by inverse-probability- weighting weights Matched analytic sample analysis
N (%) N (%) N (%) SMD SMD SMD
Age 0.197 0.037 0.022
 18 to 50 years 19 (11.6%) 26 (6.82%) 18 (48.6%)
 51 to 70 years 43 (26.2%) 105 (27.6%) 43 (50.0%)
 71 to 80 years 37 (22.6%) 75 (19.7%) 38 (50.7%)
 More than 80 years 65 (39.6%) 175 (45.9%) 65 (50.0%)
Sex 0.260 0.008 0.159
 Women 90 (54.9%) 160 (42.0%) 77 (46.1%)
 Men 74 (45.1%) 221 (58.0%) 87 (54.0%)
Hospital 0.267 0.024 0.068
 AP-HP Centre – Paris University, Henri Mondor University Hospitals and at home hospitalization 36 (22.0%) 115 (30.2%) 40 (52.6%)
 AP-HP Nord and Hôpitaux Universitaires Paris Seine-Saint-Denis 45 (27.4%) 77 (20.2%) 46 (50.5%)
 AP-HP Paris Saclay University 41 (25.0%) 113 (29.7%) 38 (48.1%)
 AP-HP Sorbonne University 42 (25.6%) 76 (19.9%) 40 (48.8%)
Obesitya 0.129 0.001 0.162
 Yes 42 (25.6%) 77 (20.2%) 31 (42.5%)
 No 122 (74.4%) 304 (79.8%) 133 (52.2%)
Number of medical conditionsb 0.321 0.015 0.029
 0 42 (25.6%) 51 (13.4%) 40 (48.8%)
 1 17 (10.4%) 37 (9.71%) 17 (50.0%)
 2 or more 105 (64.0%) 293 (76.9%) 107 (50.5%)

a Defined as having a body-mass index higher than 30 kg/m2 or an International Statistical Classification of Diseases and Related Health Problems (ICD-10) diagnosis code for obesity (E66.0, E66.1, E66.2, E66.8, E66.9).

b Assessed using ICD-10 diagnosis codes for diabetes mellitus (E11), diseases of the circulatory system (I00-I99), diseases of the respiratory system (J00-J99), neoplasms (C00-D49), diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D5-D8), frontotemporal dementia (G31.0), peptic ulcer (K27), diseases of liver (K70-K95), hemiplegia or paraplegia (G81-G82), acute kidney failure or chronic kidney disease (N17-N19), and HIV (B20).

SMD > 0.1 in bold indicate substantial differences.

SMD standardized mean difference.